CompoAtlas

Heat-treated Lacticaseibacillus rhamnosus IDCC 3201 (RHT3201®)

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Lacticaseibacillus Rhamnosus

Source : IDCC 3201

370 mgNot calculated

Non-medicinal ingredients

Amidon de maïs

PopulationAgeQuantity per servingFrequency
Enfants et Adolescentsminimum: 1 year ; maximum: 12 years1 Portions1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Supportive therapy for children with symptoms of mild atopic dermatitis. Helps support skin health in children with symptoms of atopic dermatitis. Helps to alleviate mild eczema/atopic dermatitis symptoms. Helps reduce symptoms of mild atopic dermatitis. Helps to improve clinical symptoms of mild atopic dermatitis in children with atopic dermatitis. Clinically shown to help improve symptoms of mild atopic dermatitis.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Licence holder
Ildong Bioscience Co., Ltd.
NPN or DIN-HM
80147589
Status
Active licence
Licence date
3 March 2026
Revision date
Not provided
Form
Poudre
Route of administration
Orale
Application type
Générale (non traditionelle)

Source

Official Health Canada record, licence 80147589

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Heat-treated Lacticaseibacillus rhamnosus IDCC 3201 (RHT3201®) (Ildong Bioscience Co., Ltd.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80147589-heat-treated-lacticaseibacillus-rhamnosus-idcc-3201-rht3201, updated 3 March 2026.

Enter to analyse, Shift+Enter for a new line